Trends in Human Papillomavirus (HPV) Vaccination Initiation Among Adolescents Aged 13-17 by Metropolitan Statistical Area (MSA) Status, National Immunization Survey - Teen, 2013 - 2017

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2019 Oct 31

PMID 31662024

Citations 18

Authors

Tanja Y Walker

Laurie D Elam-Evans

Charnetta L Williams

Benjamin Fredua

David Yankey

Lauri E Markowitz

Shannon Stokley

Affiliations

Soon will be listed here.

Abstract

Disparities in HPV vaccination coverage by metropolitan statistical area (MSA) status were observed in the 2016 and 2017 National Immunization Survey - Teen (NIS-Teen). In 2017, HPV vaccination initiation (≥1dose) coverage was 11 percentage points lower for adolescents living in non-MSAs (mostly rural areas) and 7 percentage points lower among those living in MSA, non-principal cities (suburban areas) compared to those living in MSA, principal cities (mostly urban areas). In order to understand how this disparity has changed over time, we examined trends in HPV vaccine initiation by MSA status from 2013 to 2017. Weighted linear regression by survey year was used to estimate annual percentage point changes in HPV vaccination initiation. The five-year average annual percentage point increases in HPV vaccination initiation coverage were 5.2 in mostly urban areas, 4.9 for suburban areas, and 5.2 for mostly rural areas. Despite increases in each MSA area, coverage in mostly rural areas was consistently and significantly lower than coverage in mostly urban areas. Coverage was significantly lower among teens living in mostly rural areas regardless of poverty status, sex, and race/ethnicity except among black, non-Hispanic adolescents. There was no significant change in the magnitude of the disparity between mostly urban areas and mostly rural areas over time ( = .98). A better understanding of the facilitators and barriers to HPV vaccination in mostly rural areas is needed to identify and implement targeted strategies to improve HPV vaccination coverage and reduce these disparities.

Citing Articles

Association of Maternal Cervical Cancer Screening Adherence with Adolescent HPV Vaccination Among Adolescent-Mother Pairs.

Tsegaye A, Lin J, Cole A, Szpiro A, Rao D, Walson J J Community Health. 2024; 49(5):857-868.

PMID: 38485802 DOI: 10.1007/s10900-024-01333-w.

Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review.

Kong W, Oh N, Kennedy K, Carlson R, Liu A, Ozawa S J Adolesc Health. 2024; 74(5):868-877.

PMID: 38231146 PMC: 11031337. DOI: 10.1016/j.jadohealth.2023.11.016.

Impact of visit characteristics on intention to recommend HPV vaccine: An experiment with US health care professionals.

Kong W, Queen T, Gottfredson OShea N, Heisler-MacKinnon J, Liu A, Ozawa S Prev Med. 2023; 179:107841.

PMID: 38160884 PMC: 10872220. DOI: 10.1016/j.ypmed.2023.107841.

Understanding HPV Vaccine Hesitancy and What Helped Hesitant Adopter Parents Have Their Children Vaccinated Despite Their Hesitancy.

Purvis R, Moore R, Willis D, Li J, Kraleti S, Imran T J Pediatr Health Care. 2023; 38(4):468-479.

PMID: 38127043 PMC: 11187701. DOI: 10.1016/j.pedhc.2023.11.013.

Barriers to Human Papillomavirus Vaccination Initiation and Completion among Adults Aged 18-26 Years in a Large Healthcare System.

Khalil L, Russo E, Venkatakrishnan K, Mazul A, Zevallos J Cancers (Basel). 2023; 15(17).

PMID: 37686521 PMC: 10487182. DOI: 10.3390/cancers15174243.

References

Brewer N, Hall M, Malo T, Gilkey M, Quinn B, Lathren C . Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial. Pediatrics. 2016; 139(1). PMC: 5192091. DOI: 10.1542/peds.2016-1764. View

Henry K, Swiecki-Sikora A, Stroup A, Warner E, Kepka D . Area-based socioeconomic factors and Human Papillomavirus (HPV) vaccination among teen boys in the United States. BMC Public Health. 2017; 18(1):19. PMC: 5513319. DOI: 10.1186/s12889-017-4567-2. View

Allison M, Hurley L, Markowitz L, Crane L, Brtnikova M, Beaty B . Primary Care Physicians' Perspectives About HPV Vaccine. Pediatrics. 2016; 137(2):e20152488. PMC: 6104512. DOI: 10.1542/peds.2015-2488. View

Ylitalo K, Lee H, Mehta N . Health care provider recommendation, human papillomavirus vaccination, and race/ethnicity in the US National Immunization Survey. Am J Public Health. 2012; 103(1):164-9. PMC: 3518336. DOI: 10.2105/AJPH.2011.300600. View

Walker T, Elam-Evans L, Yankey D, Markowitz L, Williams C, Mbaeyi S . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2017. MMWR Morb Mortal Wkly Rep. 2018; 67(33):909-917. PMC: 6107323. DOI: 10.15585/mmwr.mm6733a1. View

Monnat S, Rhubart D, Wallington S . Differences in Human Papillomavirus Vaccination Among Adolescent Girls in Metropolitan Versus Non-metropolitan Areas: Considering the Moderating Roles of Maternal Socioeconomic Status and Health Care Access. Matern Child Health J. 2015; 20(2):315-25. PMC: 4740204. DOI: 10.1007/s10995-015-1831-x. View

Mohammed K, Subramaniam D, Geneus C, Henderson E, Dean C, Subramaniam D . Rural-urban differences in human papillomavirus knowledge and awareness among US adults. Prev Med. 2018; 109:39-43. DOI: 10.1016/j.ypmed.2018.01.016. View

Walker T, Elam-Evans L, Singleton J, Yankey D, Markowitz L, Fredua B . National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13-17 Years - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017; 66(33):874-882. PMC: 5687818. DOI: 10.15585/mmwr.mm6633a2. View

Saraiya M, Unger E, Thompson T, Lynch C, Hernandez B, Lyu C . US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 2015; 107(6):djv086. PMC: 4838063. DOI: 10.1093/jnci/djv086. View

10.

Meites E, Kempe A, Markowitz L . Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016; 65(49):1405-1408. DOI: 10.15585/mmwr.mm6549a5. View

11.

Shipman S, Lan J, Chang C, Goodman D . Geographic maldistribution of primary care for children. Pediatrics. 2010; 127(1):19-27. PMC: 3010089. DOI: 10.1542/peds.2010-0150. View

12.

Markowitz L, Dunne E, Saraiya M, Chesson H, Curtis C, Gee J . Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014; 63(RR-05):1-30. View

13.

Landis K, Bednarczyk R, Gaydos L . Correlates of HPV vaccine initiation and provider recommendation among male adolescents, 2014 NIS-Teen. Vaccine. 2018; 36(24):3498-3504. PMC: 6550295. DOI: 10.1016/j.vaccine.2018.04.075. View

14.

Kornides M, McRee A, Gilkey M . Parents Who Decline HPV Vaccination: Who Later Accepts and Why?. Acad Pediatr. 2018; 18(2S):S37-S43. PMC: 5859546. DOI: 10.1016/j.acap.2017.06.008. View

15.

Gilkey M, Malo T, Shah P, Hall M, Brewer N . Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomarkers Prev. 2015; 24(11):1673-9. PMC: 4633386. DOI: 10.1158/1055-9965.EPI-15-0326. View

16.

Gilkey M, Calo W, Moss J, Shah P, Marciniak M, Brewer N . Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine. 2016; 34(9):1187-92. PMC: 4944755. DOI: 10.1016/j.vaccine.2016.01.023. View

17.

OLeary S, Lockhart S, Barnard J, Furniss A, Dickinson M, Dempsey A . Exploring Facilitators and Barriers to Initiation and Completion of the Human Papillomavirus (HPV) Vaccine Series among Parents of Girls in a Safety Net System. Int J Environ Res Public Health. 2018; 15(2). PMC: 5858260. DOI: 10.3390/ijerph15020185. View

18.

Van Dyne E, Henley S, Saraiya M, Thomas C, Markowitz L, Benard V . Trends in Human Papillomavirus-Associated Cancers - United States, 1999-2015. MMWR Morb Mortal Wkly Rep. 2018; 67(33):918-924. PMC: 6107321. DOI: 10.15585/mmwr.mm6733a2. View

19.

Curtis C, Dorell C, Yankey D, Jeyarajah J, Chesson H, Saraiya M . National human papillomavirus vaccination coverage among adolescents aged 13-17 years-National Immunization Survey--teen, United States, 2011. MMWR Suppl. 2014; 63(2):61-70. View

20.

. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. 2011; 60(50):1705-8. View